These observations are of particular importance, since growth assays failed to reveal an anti-proliferative effect of CRH on ovarian cancer cells, which is in contrast with what has been reported on human endometrial and breast cancer cells (Graziani et al, 2002, 2007). This evidence concerns the gene CRH and breast carcinoma.